dipyrone has been researched along with Coronary Artery Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bilkova, J; Hartinger, J; Hlubocky, J; Kvasnicka, J; Kvasnicka, T; Lindner, J; Mitas, P; Novotny, R; Sima, M; Slanar, O | 1 |
| Achilles, A; Dannenberg, L; Grandoch, M; Helten, C; Hohlfeld, T; Kelm, M; Levkau, B; M'Pembele, R; Mourikis, P; Naguib, D; Petzold, T; Podsvyadek, Y; Polzin, A; Zako, S; Zeus, T | 1 |
| Hohlfeld, T; Kelm, M; Polzin, A; Schrör, K; Zeus, T | 1 |
| Hohlfeld, T; Kelm, M; Merx, MW; Polzin, A; Rassaf, T; Richter, S; Schrör, K; Zeus, T | 1 |
| Achilles, A; Dannenberg, L; Hohlfeld, T; Kelm, M; Levkau, B; Mohring, A; Piayda, K; Polzin, A; Zeus, T | 1 |
1 trial(s) available for dipyrone and Coronary Artery Disease
| Article | Year |
|---|---|
Prevention of dipyrone (metamizole) induced inhibition of aspirin antiplatelet effects.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Aspirin; Biomarkers; Blood Platelets; Chromatography, High Pressure Liquid; Coronary Artery Disease; Cross-Over Studies; Dipyrone; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Female; Humans; Male; Middle Aged; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Thromboxane B2 | 2015 |
4 other study(ies) available for dipyrone and Coronary Artery Disease
| Article | Year |
|---|---|
Role of Dipyrone in the High On-Treatment Platelet Reactivity amongst Acetylsalicylic Acid-Treated Patients Undergoing Peripheral Artery Revascularisation.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Catheterization, Peripheral; Coronary Artery Disease; Dipyrone; Drug Interactions; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Regression Analysis | 2018 |
Dose reduction, oral application, and order of intake to preserve aspirin antiplatelet effects in dipyrone co-medicated chronic artery disease patients.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Aspirin; Coronary Artery Disease; Dipyrone; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors | 2019 |
Dipyrone (metamizole) can nullify the antiplatelet effect of aspirin in patients with coronary artery disease.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Coronary Artery Disease; Dipyrone; Drug Interactions; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Thromboxanes | 2013 |
Analgesic medication with dipyrone in patients with coronary artery disease: Relation to MACCE.
Topics: Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Aspirin; Chest Pain; Coronary Artery Disease; Dipyrone; Drug Interactions; Female; Germany; Humans; Male; Middle Aged; Myocardial Infarction; Pilot Projects; Platelet Aggregation Inhibitors; Risk Assessment; Stroke; Treatment Outcome | 2017 |